Dear Doctor - Participate in the Survey on hepatitis of unknown etiology " A recent survey of hepatitis cases of unknown etiology in children found that the vast majority of cases were in infants under the age of 6 months. The most common symptoms reported were fever, diarrhea, and vomiting. However, a small number of children also had jaundice and liver enzymes that were elevated. The most common tests used to diagnose hepatitis are the alanine aminotransferase (ALT) test and the aspartate aminotransferase (AST) test. These tests can be used to identify liver damage and determine the cause of the hepatitis. In some cases, additional testing, such as a viral load test or a liver biopsy, may be needed to confirm the diagnosis. Treatment for hepatitis usually involves supportive care, such as rest and fluids, and may also include medications to reduce liver inflammation or suppress the immune system. Participate in Surveys "
1.
Gene therapy for glioblastoma is effectively created by researchers.
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
3D virtual staining technology enables non-invasive observation of cancer tissue
4.
New policy review highlights the importance of health-related quality of life in advanced cancer
5.
Some triple negative breast cancers might be avoided by longer breastfeeding
1.
Advancements in Survival Mechanisms and Prognostic Determinants in Acute Myeloid Leukemia
2.
Understanding Evans Syndrome: Causes, Symptoms, and Treatment Options
3.
Unlocking the Secrets of Hemoglobin: How It Works to Keep Us Healthy
4.
What You Need To Know About Trametinib: A Miracle Cancer Treatment?
5.
Case Study: Artificial Intelligence in Early Cancer Detection
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
4.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation